Northwest & Ethical Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40M Sell
311,108
-40,621
-12% -$4.75M 0.93% 20
2026
Q1
$42.3M Buy
351,729
+23,081
+7% +$2.66M 0.98% 18
2025
Q4
$34.6M Buy
328,648
+24,118
+8% +$2.26M 0.78% 27
2025
Q3
$25.6M Buy
304,530
+1,970
+0.7% +$162K 0.6% 45
2025
Q2
$24M Sell
302,560
-73,132
-19% -$5.81M 0.59% 49
2025
Q1
$33.7M Buy
375,692
+84,063
+29% +$7.85M 0.91% 19
2024
Q4
$29M Buy
291,629
+13,664
+5% +$1.41M 0.79% 27
2024
Q3
$31.6M Buy
277,965
+247
+0.1% +$29.3K 0.83% 22
2024
Q2
$34.4M Sell
277,718
-10
-0% -$1.29K 0.99% 17
2024
Q1
$36.6M Buy
277,728
+12,270
+5% +$1.51M 1.06% 16
2023
Q4
$28.9M Sell
265,458
-8,831
-3% -$917K 0.89% 22
2023
Q3
$28.2M Sell
274,289
-2,258
-0.8% -$243K 0.95% 19
2023
Q2
$31.9M Buy
276,547
+12,708
+5% +$1.44M 1.02% 16
2023
Q1
$28.1M Sell
263,839
-16,759
-6% -$1.81M 0.93% 20
2022
Q4
$31.1M Buy
280,598
+60,994
+28% +$6.23M 1.08% 14
2022
Q3
$18.9M Sell
219,604
-1,140
-0.5% -$102K 0.76% 31
2022
Q2
$20.1M Buy
220,744
+53,434
+32% +$4.74M 0.75% 33
2022
Q1
$13.7M Sell
167,310
-41,819
-20% -$3.3M 0.44% 72
2021
Q4
$16M Sell
209,129
-30,346
-13% -$2.42M 0.47% 67
2021
Q3
$18M Buy
239,475
+25,952
+12% +$1.97M 0.59% 56
2021
Q2
$16.6M Sell
213,523
-52,666
-20% -$3.92M 0.54% 64
2021
Q1
$19.6M Sell
266,189
-3,980
-1% -$294K 0.69% 41
2020
Q4
$21.1M Sell
270,169
-7,569
-3% -$579K 0.81% 30
2020
Q3
$22M Buy
277,738
+24,347
+10% +$1.91M 0.97% 17
2020
Q2
$18.7M Buy
253,391
+45,162
+22% +$3.4M 0.89% 22
2020
Q1
$15.3M Buy
208,229
+12,904
+7% +$1.01M 0.89% 17
2019
Q4
$16.9M Buy
195,325
+27,174
+16% +$2.23M 0.76% 30
2019
Q3
$13.5M Buy
168,151
+26,426
+19% +$2.12M 0.66% 34
2019
Q2
$11.3M Buy
141,725
+4,366
+3% +$334K 0.57% 42
2019
Q1
$10.9M Buy
137,359
+60,812
+79% +$4.55M 0.57% 43
2018
Q4
$5.58M Buy
76,547
+36,547
+91% +$2.58M 0.33% 92
2018
Q3
$2.71M Buy
40,000
+5,869
+17% +$374K 0.17% 175
2018
Q2
$1.98M Sell
34,131
-39,416
-54% -$2.22M 0.13% 221
2018
Q1
$3.82M Sell
73,547
-3,311
-4% -$179K 0.26% 117
2017
Q4
$4.13M Sell
76,858
-51,649
-40% -$2.86M 0.27% 115
2017
Q3
$7.85M Buy
128,507
+4,266
+3% +$259K 0.49% 44
2017
Q2
$7.6M Buy
124,241
+27,819
+29% +$1.69M 0.52% 41
2017
Q1
$5.85M Buy
96,422
+30,919
+47% +$1.88M 0.4% 55
2016
Q4
$3.68M Buy
65,503
+34,348
+110% +$2.01M 0.25% 100
2016
Q3
$1.86M Buy
+31,155
New +$1.82M 0.13% 173
2015
Q4
Sell
-151,488
Closed -$7.14M 213
2015
Q3
$7.14M Buy
151,488
+7,556
+5% +$401K 0.55% 51
2015
Q2
$7.82M Buy
+143,932
New +$8.07M 0.52% 58
2015
Q1
Sell
-43,597
Closed -$2.36M 225
2014
Q4
$2.36M Sell
43,597
-141,585
-76% -$7.89M 0.16% 141
2014
Q3
$10.5M Sell
185,182
-310,470
-63% -$17.4M 0.7% 31
2014
Q2
$27.4M Sell
495,652
-11,947
-2% -$652K 1.7% 13
2014
Q1
$27.5M Sell
507,599
-1,362
-0.3% -$70.5K 1.8% 14
2013
Q4
$24.3M Buy
508,961
+130,476
+34% +$5.96M 1.61% 13
2013
Q3
$17.2M Sell
378,485
-2,306
-0.6% -$105K 1.25% 17
2013
Q2
$16.9M Buy
+380,791
New +$17M 1.32% 18

Other funds holding MRK

Northwest & Ethical Investments's MRK Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its Merck (MRK) stake by 12% in Q2 2026, selling an estimated $4.75M and leaving 311,108 shares worth $40M. The position accounts for 0.93% of the portfolio, ranked #20.

Northwest & Ethical Investments first reported a position in MRK in Q2 2013 and has held it in 49 quarters since. The position peaked at $42.3M in Q1 2026. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Northwest & Ethical Investments held 311,108 shares of Merck worth $40M as of Q2 2026.
  • Northwest & Ethical Investments sold 40,621 Merck shares in Q2 2026, an estimated $4.75M.
  • Merck made up 0.93% of Northwest & Ethical Investments's portfolio in Q2 2026, its #20 holding.
  • Northwest & Ethical Investments first reported a position in Merck in Q2 2013 and has held it in 49 quarters since.
  • Northwest & Ethical Investments's Merck position peaked at $42.3M in Q1 2026.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.